Literature DB >> 32640907

Nicotine Modulates CTSS (Cathepsin S) Synthesis and Secretion Through Regulating the Autophagy-Lysosomal Machinery in Atherosclerosis.

Huaner Ni1, Shuang Xu1, Hangwei Chen1, Qiuyan Dai1.   

Abstract

OBJECTIVE: Increased CTSS (cathepsin S) has been reported to play a critical role in atherosclerosis progression. Both CTSS synthesis and secretion are essential for exerting its functions. However, the underlying mechanisms contributing to CTSS synthesis and secretion in atherosclerosis remain unclear. Approach and
Results: In this study, we showed that nicotine activated autophagy and upregulated CTSS expression in vascular smooth muscle cells and in atherosclerotic plaques. Western blotting and immunofluorescent staining showed that nicotine inhibited the mTORC1 activity, promoted the nuclear translocation of TFEB (transcription factor EB), and upregulated the expression of CTSS. Chromatin immunoprecipitation-qualificative polymerase chain reaction, electrophoretic mobility shift assay, and luciferase reporter assay further demonstrated that TFEB directly bound to the CTSS promoter. mTORC1 inhibition by nicotine or rapamycin promoted lysosomal exocytosis and CTSS secretion. Live cell assays and IP-mass spectrometry identified that the interactions involving Rab10 and mTORC1 control CTSS secretion. Nicotine promoted vascular smooth muscle cell migration by upregulating CTSS, and CTSS inhibition suppressed nicotine-induced atherosclerosis in vivo.
CONCLUSIONS: We concluded that nicotine mediates CTSS synthesis and secretion through regulating the autophagy-lysosomal machinery, which offers a potential therapeutic target for atherosclerosis treatment.

Entities:  

Keywords:  atherosclerosis; autophagy; ion channels; nicotine; staining and labeling

Year:  2020        PMID: 32640907     DOI: 10.1161/ATVBAHA.120.314053

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  8 in total

1.  Integrated Multiomics Analysis Identifies a Novel Biomarker Associated with Prognosis in Intracerebral Hemorrhage.

Authors:  Yiqing Shen; Wensong Yang; Xin Xiong; Xinhui Li; Zhongsong Xiao; Jialun Yu; Fangyu Liu; Siwen Gui; Xiongfei Xie; Fajin Lv; Libo Zhao; Liangbo Hu; Anatol Manaenko; Peng Xie; Qi Li
Journal:  Oxid Med Cell Longev       Date:  2021-12-14       Impact factor: 7.310

2.  Transcription factor EB promotes rheumatoid arthritis of Sprague-Dawley rats via regulating autophagy.

Authors:  De Lai Xu; Jie Pan
Journal:  3 Biotech       Date:  2021-03-09       Impact factor: 2.406

Review 3.  Different types of cell death in vascular diseases.

Authors:  Shirin Saberianpour; Abbas Karimi; Mohammad Hadi Saeed Modaghegh; Mahdi Ahmadi
Journal:  Mol Biol Rep       Date:  2021-05-19       Impact factor: 2.316

Review 4.  Transcription factor EB regulates cardiovascular homeostasis.

Authors:  Haocheng Lu; Jinjian Sun; Milton H Hamblin; Y Eugene Chen; Yanbo Fan
Journal:  EBioMedicine       Date:  2021-01-05       Impact factor: 8.143

Review 5.  Autophagy, Pyroptosis, and Ferroptosis: New Regulatory Mechanisms for Atherosclerosis.

Authors:  Lin Lin; Mu-Xin Zhang; Lei Zhang; Dan Zhang; Chao Li; Yun-Lun Li
Journal:  Front Cell Dev Biol       Date:  2022-01-13

Review 6.  Lifetime Impact of Cow's Milk on Overactivation of mTORC1: From Fetal to Childhood Overgrowth, Acne, Diabetes, Cancers, and Neurodegeneration.

Authors:  Bodo C Melnik
Journal:  Biomolecules       Date:  2021-03-09

7.  SARS-CoV-2 Infects Endothelial Cells In Vivo and In Vitro.

Authors:  Fengming Liu; Kun Han; Robert Blair; Kornelia Kenst; Zhongnan Qin; Berin Upcin; Philipp Wörsdörfer; Cecily C Midkiff; Joseph Mudd; Elizaveta Belyaeva; Nicholas S Milligan; Tyler D Rorison; Nicole Wagner; Jochen Bodem; Lars Dölken; Bertal H Aktas; Richard S Vander Heide; Xiao-Ming Yin; Jay K Kolls; Chad J Roy; Jay Rappaport; Süleyman Ergün; Xuebin Qin
Journal:  Front Cell Infect Microbiol       Date:  2021-07-06       Impact factor: 5.293

8.  Endothelial cell infection and dysfunction, immune activation in severe COVID-19.

Authors:  Zhongnan Qin; Fengming Liu; Robert Blair; Chenxiao Wang; Haoran Yang; Joseph Mudd; Joshua M Currey; Naoki Iwanaga; Jibao He; Ren Mi; Kun Han; Cecily C Midkiff; Mohammad Afaque Alam; Bertal H Aktas; Richard S Vander Heide; Ronald Veazey; Giovanni Piedimonte; Nicholas J Maness; Süleyman Ergün; Franck Mauvais-Jarvis; Jay Rappaport; Jay K Kolls; Xuebin Qin
Journal:  Theranostics       Date:  2021-07-06       Impact factor: 11.556

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.